Symbols / SCD Stock $15.42 -1.15% LMP Capital and Income Fund Inc.
SCD (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteLMP Capital and Income Fund Inc. is a closed ended balanced mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. It is co-managed by Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating across diversified sectors. The fund primarily invests in stocks of large-cap companies, intermediate period corporate bonds and notes rated at least A-, energy and non-energy master limited partnerships, and real estate investment trusts. It focuses on such factors as economic, market, or political conditions, fiscal and monetary policy, and security valuation to create its portfolio. The fund benchmarks the performance of its portfolio against the U.S. Aggregate Index and S&P 500 Index. It was formerly known as Salomon Brothers Capital and Income Fund Inc. LMP Capital and Income Fund Inc. was formed on November 12, 2003 and is domiciled in the United States.
Ratings
News
RSS: Latest SCD news- Fulcrum drops work on SCD drug pociredir; stock plummets - BioWorld News ue, 02 Jun 2026 16
- (SCD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily Fri, 15 May 2026 07
- Agios Stock Sinks 23% as NVO's PKR Activator Meets Goal in SCD Study - Yahoo Finance ue, 21 Apr 2026 07
- SMCD-P.CA Stock Chart | SCD CAPITAL CORP (TSX-V:SMCD-P) - ChartMill hu, 28 May 2026 07
- BofA raises Agios Pharma stock price target on SCD filing path - Investing.com ue, 31 Mar 2026 07
- SCD: Unique CEF Could Be Well-Positioned To Outperform In The Current Environment - Seeking Alpha ue, 07 Apr 2026 07
- Experimental sickle cell therapy aims to restore healthy red blood cells - Stock Titan ue, 12 May 2026 07
- Agios readies FDA push in sickle cell disease despite mixed ph. 3 results, shares plummet - Fierce Pharma Wed, 19 Nov 2025 08
- Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why - TradingView Wed, 18 Mar 2026 07
- TiumBio·DT&CRO Shares Rise on Expectations of Improved Earnings...SCD Pharm Shares Fall for a Se... - 팜이데일리 Wed, 08 Apr 2026 07
- (SCD) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily ue, 26 May 2026 16
- Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why - Yahoo Finance Wed, 18 Mar 2026 07
- Promising New Weight-Loss Pill From South Korea’s Sam Chun Dang Pharm Mints Country’s Newest Billionaire - Forbes Mon, 26 Jan 2026 08
- New pediatric AKI data show 69% survival with no device issues - Stock Titan Mon, 30 Mar 2026 07
- AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - TradingView Wed, 01 Apr 2026 07
Financials
| Line Item | Trend | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 |
|---|---|---|---|---|---|
| Total Revenue |
|
-0.07
-100.08%
|
87.86
+241.19%
|
25.75
+1094.61%
|
-2.59
|
| Operating Revenue |
|
-0.07
-100.08%
|
87.86
+241.19%
|
25.75
+1094.61%
|
-2.59
|
| Operating Expense |
|
0.75
+14.96%
|
0.65
+48.31%
|
0.44
-0.15%
|
0.44
|
| Selling General And Administration |
|
0.62
+19.91%
|
0.52
+66.36%
|
0.31
-5.68%
|
0.33
|
| General And Administrative Expense |
|
0.62
+19.91%
|
0.52
+66.36%
|
0.31
-5.68%
|
0.33
|
| Other Operating Expenses |
|
0.13
-4.19%
|
0.13
+4.48%
|
0.13
+16.46%
|
0.11
|
| Net Income |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Pretax Income |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Net Interest Income |
|
-2.84
+13.56%
|
-3.28
-2.07%
|
-3.22
-196.62%
|
-1.08
|
| Interest Expense |
|
3.71
-9.08%
|
4.08
+17.73%
|
3.46
+176.12%
|
1.25
|
| Interest Income |
|
0.87
+9.48%
|
0.79
+222.34%
|
0.25
+45.11%
|
0.17
|
| Gain On Sale Of Security |
|
46.47
+31.67%
|
35.29
+73.31%
|
20.36
+274.93%
|
5.43
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Net Income From Continuing Operation Net Minority Interest |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Net Income From Continuing And Discontinued Operation |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Net Income Continuous Operations |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Normalized Income |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Net Income Common Stockholders |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Diluted EPS |
|
—
|
5.00
+244.59%
|
1.45
+922.22%
|
-0.18
|
| Basic EPS |
|
—
|
5.00
+244.59%
|
1.45
+922.22%
|
-0.18
|
| Basic Average Shares |
|
—
|
17.44
-0.01%
|
17.44
+1.56%
|
17.17
|
| Diluted Average Shares |
|
—
|
17.44
-0.01%
|
17.44
+1.56%
|
17.17
|
| Diluted NI Availto Com Stockholders |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Line Item | Trend | 2023-11-30 |
|---|---|---|
| Total Assets |
|
318.75
|
| Cash And Cash Equivalents |
|
—
|
| Cash Financial |
|
—
|
| Receivables |
|
0.66
|
| Prepaid Assets |
|
0.00
|
| Investments And Advances |
|
318.09
|
| Total Liabilities Net Minority Interest |
|
63.32
|
| Payables |
|
2.17
|
| Accounts Payable |
|
1.95
|
| Other Payable |
|
0.23
|
| Long Term Debt And Capital Lease Obligation |
|
61.00
|
| Stockholders Equity |
|
255.43
|
| Common Stock Equity |
|
255.43
|
| Capital Stock |
|
0.02
|
| Common Stock |
|
0.02
|
| Share Issued |
|
17.48
|
| Ordinary Shares Number |
|
17.48
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
155.72
|
| Retained Earnings |
|
99.69
|
| Total Equity Gross Minority Interest |
|
255.43
|
| Total Capitalization |
|
316.43
|
| Invested Capital |
|
316.43
|
| Total Debt |
|
61.00
|
| Net Debt |
|
61.00
|
| Net Tangible Assets |
|
255.43
|
| Tangible Book Value |
|
255.43
|
| Available For Sale Securities |
|
4.34
|
| Cash Cash Equivalents And Federal Funds Sold |
|
—
|
| Financial Assets Designatedas Fair Value Through Profitor Loss Total |
|
313.75
|
| Investmentin Financial Assets |
|
318.09
|
| Line Item | Trend | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-73.28
-534.95%
|
16.85
-31.58%
|
24.62
+12.03%
|
21.98
|
| Net Income From Continuing Operations |
|
-0.82
-100.94%
|
87.21
+244.55%
|
25.31
+935.08%
|
-3.03
|
| Other Non Cash Items |
|
2.44
-17.36%
|
2.95
-60.83%
|
7.53
+45.72%
|
5.17
|
| Gain Loss On Investment Securities |
|
-74.53
-1.30%
|
-73.57
-758.90%
|
-8.57
-141.10%
|
20.84
|
| Change In Working Capital |
|
-0.36
-273.21%
|
0.21
+2.89%
|
0.20
+120.36%
|
-1.00
|
| Change In Receivables |
|
-0.20
-371.14%
|
0.07
-37.24%
|
0.12
-76.69%
|
0.50
|
| Change In Prepaid Assets |
|
0.00
-13.57%
|
0.00
+133.42%
|
-0.00
-295.89%
|
0.00
|
| Change In Accrued Expense |
|
0.02
-57.26%
|
0.06
-34.86%
|
0.09
+826.90%
|
0.01
|
| Change In Payable |
|
0.03
-57.74%
|
0.08
+5416.59%
|
0.00
+100.10%
|
-1.51
|
| Change In Other Current Liabilities |
|
-0.23
|
0.00
|
0.00
|
0.00
|
| Financing Cash Flow |
|
73.28
+534.95%
|
-16.85
+31.58%
|
-24.62
-11.64%
|
-22.06
|
| Net Issuance Payments Of Debt |
|
13.00
+116.67%
|
6.00
|
—
|
0.00
|
| Issuance Of Debt |
|
13.00
+116.67%
|
6.00
|
—
|
61.00
|
| Repayment Of Debt |
|
—
|
—
|
—
|
-61.00
|
| Long Term Debt Issuance |
|
13.00
+116.67%
|
6.00
|
—
|
61.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
-61.00
|
| Net Long Term Debt Issuance |
|
13.00
+116.67%
|
6.00
|
—
|
0.00
|
| Net Common Stock Issuance |
|
87.17
|
—
|
-3.41
+11.25%
|
-3.84
|
| Common Stock Payments |
|
—
|
—
|
-3.41
+11.25%
|
-3.84
|
| Common Stock Dividend Paid |
|
-26.89
-16.19%
|
-23.14
-9.09%
|
-21.21
-16.46%
|
-18.22
|
| Cash Dividends Paid |
|
-26.89
-16.19%
|
-23.14
-9.09%
|
-21.21
-16.46%
|
-18.22
|
| Repurchase Of Capital Stock |
|
—
|
—
|
-3.41
+11.25%
|
-3.84
|
| Net Other Financing Charges |
|
0.00
-99.74%
|
0.30
|
0.00
|
0.00
|
| Changes In Cash |
|
0.00
|
0.00
|
0.00
+100.00%
|
-0.08
|
| Beginning Cash Position |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.08
|
| End Cash Position |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Free Cash Flow |
|
-73.28
-534.95%
|
16.85
-31.58%
|
24.62
+12.03%
|
21.98
|
| Common Stock Issuance |
|
87.17
|
—
|
—
|
—
|
| Issuance Of Capital Stock |
|
87.17
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42025-07-15 View
- 42025-05-28 View
- 8-K2024-11-20 View
- 42024-06-24 View
- 42022-12-21 View
- 8-K2022-04-01 View
- 42022-01-07 View
- 8-K2020-08-18 View
- 8-K2020-04-03 View
- 8-K2020-04-02 View
- 42020-03-17 View
- 42020-03-16 View
- 42020-01-23 View
- 8-K2019-11-05 View
- 42019-02-13 View
- 42019-01-03 View
- 8-K2019-01-02 View
- 42019-01-02 View
- 42018-04-18 View
- 42018-01-04 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|